Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190427043389N4
IRCT20190427043389N4
Not yet recruiting
Phase 3

The effectiveness of the combination of Memantine and Betahistine on insomnia severity, quality of life and severity of symptoms in people with primary tinnitus

Zanjan University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Zanjan University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Having primary tinnitus for more than 3 months
  • •Willingness and interest to participate in the study
  • •Having moderate intensity of insomnia (scoring more than 15 based on the ISI Insomnia Severity Questionnaire)

Exclusion Criteria

  • •Tinnitus due to anatomical disease
  • •Previous use of memantine
  • •History of high blood pressure
  • •Suffering from chronic and debilitating diseases as diagnosed by the attending physician
  • •Known mental illness
  • •Concomitant use of medications that interact with memantine
  • •contraindication of memantine by the doctors diagnosis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
The efficacy of complementory use of memantine in treatment of schizophrenia with chronic courseSchizophrenia.Schizophrenia
IRCT201306015605N1Clinical psychiatry research center, Tabriz university of medical sciences60
Completed
Phase 2
Memantine effect in the treatment of residual symptoms in patients with schizophrenia
IRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
Completed
Phase 3
Comparing efficacy and side effects of Memantine and Risperidone in treating autistic patientsAutism.Pervasive developmental disorders
IRCT201204037202N5Tehran University of Medical Sciences30
Recruiting
Phase 3
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0
IRCT20160310026998N12Tabriz University of Medical Sciences180
Completed
Phase 3
se of memantin in treatment of adult with attention deficit hyperactivity disorderAdult ADHD (Attention-deficit hyperactivity disorder ).Disturbance of activity and attention
IRCT2016053028182N1Kurdistan University of Medical science40